Marinomed Biotech

Marinomed Biotech AG is an Austrian biopharmaceutical company, founded in 2006, specializing in the development of innovative products based on IP protected technology platforms. The company focuses on addressing the challenges of hardly soluble active pharmaceutical ingredients (APIs) in drug development through its clinically proven technology Marinosolv®. This technology enables the creation of customized aqueous formulations to enhance bioavailability and therapeutic efficacy. Marinomed Biotech is dedicated to researching and developing therapies aimed at treating respiratory and ophthalmic conditions, providing valuable solutions to the pharmaceutical industry.

Services include:
- Drug Delivery Devices & Systems
- Finished Dosage Forms

Marinomed Biotech continues to advance its technology platforms and contribute to the pharmaceutical sector with innovative approaches. For more information, please visit marinomed.com.